This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,513 Years Active: 2006
Title: Eric Boettger: Innovator in Mycobacterial Therapy
Introduction
Eric Boettger is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of immunotherapy through his innovative work with mycobacteria. His research focuses on developing therapeutic agents that can combat various disorders, including tuberculosis.
Latest Patents
Eric Boettger holds a patent for "Mutant mycobacteria for use in therapy." This invention pertains to recA mutant mycobacteria, particularly those that are members of the complex, such as BCG. These mutant mycobacteria serve as immunotherapeutic agents and vaccines, providing a promising approach to treating a range of disorders.
Career Highlights
Throughout his career, Eric has demonstrated a commitment to advancing medical science. His work has the potential to impact public health significantly, particularly in the fight against tuberculosis. With 1 patent to his name, he continues to explore innovative solutions in the field of therapy.
Collaborations
Eric collaborates with Kay Colston, who serves as a Legal Representative. Their partnership highlights the importance of legal expertise in navigating the complexities of patenting and commercialization in the field of medical innovations.
Conclusion
Eric Boettger's contributions to the field of mycobacterial therapy exemplify the impact of innovative thinking in medicine. His work not only addresses critical health challenges but also paves the way for future advancements in immunotherapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile